240 related articles for article (PubMed ID: 26133668)
1. The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.
Husarek KE; Katz PS; Trask AJ; Galantowicz ML; Cismowski MJ; Lucchesi PA
Vascul Pharmacol; 2016 Jan; 76():28-36. PubMed ID: 26133668
[TBL] [Abstract][Full Text] [Related]
2. Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.
Katz PS; Trask AJ; Souza-Smith FM; Hutchinson KR; Galantowicz ML; Lord KC; Stewart JA; Cismowski MJ; Varner KJ; Lucchesi PA
Basic Res Cardiol; 2011 Nov; 106(6):1123-34. PubMed ID: 21744279
[TBL] [Abstract][Full Text] [Related]
3. Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training.
Trask AJ; Delbin MA; Katz PS; Zanesco A; Lucchesi PA
Vascul Pharmacol; 2012; 57(5-6):187-93. PubMed ID: 22885305
[TBL] [Abstract][Full Text] [Related]
4. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo.
McEwan PE; Gray GA; Sherry L; Webb DJ; Kenyon CJ
Circulation; 1998 Dec; 98(24):2765-73. PubMed ID: 9851965
[TBL] [Abstract][Full Text] [Related]
6. Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.
Zhang J; Qu HY; Song J; Wei J; Jiang S; Wang L; Wang L; Buggs J; Liu R
Physiol Genomics; 2017 Oct; 49(10):531-540. PubMed ID: 28842434
[TBL] [Abstract][Full Text] [Related]
7. Early treatment with losartan effectively ameliorates hypertension and improves vascular remodeling and function in a prehypertensive rat model.
He DH; Lin JX; Zhang LM; Xu CS; Xie Q
Life Sci; 2017 Mar; 173():20-27. PubMed ID: 28161159
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature.
Yamasaki E; Thakore P; Krishnan V; Earley S
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H461-H469. PubMed ID: 31886721
[TBL] [Abstract][Full Text] [Related]
10. Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.
Carrillo-Sepulveda MA; Keen HL; Davis DR; Grobe JL; Sigmund CD
PLoS One; 2014; 9(8):e103786. PubMed ID: 25122005
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.
Chu KY; Lau T; Carlsson PO; Leung PS
Diabetes; 2006 Feb; 55(2):367-74. PubMed ID: 16443769
[TBL] [Abstract][Full Text] [Related]
12. Impaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC, and NAD(P)H oxidase.
Huang A; Yan C; Suematsu N; Cuevas A; Yang YM; Kertowidjojo E; Hintze TH; Kaley G; Sun D
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1476-83. PubMed ID: 20833958
[TBL] [Abstract][Full Text] [Related]
13. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
Chan SL; Umesalma S; Baumbach GL
Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockade in juvenile male rat offspring: Implications for long-term cardio-renal health.
Walton SL; Mazzuca MQ; Tare M; Parkington HC; Wlodek ME; Moritz KM; Gallo LA
Pharmacol Res; 2018 Aug; 134():320-331. PubMed ID: 29870806
[TBL] [Abstract][Full Text] [Related]
17. Reduced stiffness and augmented traction force in type 2 diabetic coronary microvascular smooth muscle.
McCallinhart PE; Cho Y; Sun Z; Ghadiali S; Meininger GA; Trask AJ
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1410-H1419. PubMed ID: 32357115
[TBL] [Abstract][Full Text] [Related]
18. Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.
Arrick DM; Sharpe GM; Sun H; Mayhan WG
Brain Res; 2008 May; 1209():128-35. PubMed ID: 18400212
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
